ADVFN - ニュース

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/31	02 : 26	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	02 : 25	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/31	02 : 24	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:BML-L	Bank of America Corporation
2024/07/31	02 : 23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:PUK	Prudential Plc
2024/07/31	02 : 23	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	02 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MEDP	Medpace Holdings Inc
2024/07/31	02 : 23	Business Wire	Aelis Farma: Launch of a Reserved Offering of Approximately €5 Million	EU:AELIS	Aelis Farma SA
2024/07/31	02 : 23	Business Wire	Aelis Farma : Lancement d’une Offre Réservée d'un montant d’environ 5 millions d'euros	EU:AELIS	Aelis Farma SA
2024/07/31	02 : 22	PR Newswire (US)	Health Net Providing Special Assistance to Members Affected by the Gold Complex and Park Fires Throughout California	NYSE:CNC	Centene Corp
2024/07/31	02 : 21	Edgar (US Regulatory)	Form N-PX - Annual Report of proxy voting record of management investment companies	NYSE:ORI	Old Republic International Corp
2024/07/31	02 : 21	PR Newswire (US)	Cancer Research in Space for Life on Earth: Five Projects Selected Through ISS National Lab Solicitation in Partnership With NASA
2024/07/31	02 : 20	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/07/31	02 : 20	PR Newswire (US)	BluSky Earns Seventh Consecutive Designation As Great Place to Work Certified™ Company
2024/07/31	02 : 20	PR Newswire (US)	Freddy's partners with Kids In Need Foundation in August fundraiser
2024/07/31	02 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:RTX	RTX Corporation
2024/07/31	02 : 19	PR Newswire (Canada)	LE MÉDICAMENT GLP-1 LIRAGLUTIDE PEUT PROTÉGER CONTRE LA DÉMENCE
2024/07/31	02 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:SHW	Sherwin Williams
2024/07/31	02 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	02 : 17	PR Newswire (US)	Mployer Announces 2024 Winners of Fourth Annual 'Top Employee Benefits Consultant Awards' in Northern Ohio
2024/07/31	02 : 16	GlobeNewswire Inc.	PassiveLogic Awarded Red Dot Design Award for Sense Nano Product Design
2024/07/31	02 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:XYL	Xylem Inc
2024/07/31	02 : 16	PR Newswire (US)	Metabolize Licenses Two Proprietary Metabolites to Address Obesity from Stanford OTL
2024/07/31	02 : 15	GlobeNewswire Inc.	Harnessing Innovation at the 2024 NYS Public Safety UAS Summit
2024/07/31	02 : 15	PR Newswire (US)	Doug Sundstrom Joins Gildred Companies as Vice President Investments
2024/07/31	02 : 14	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/31	02 : 14	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/07/31	02 : 14	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NYSE:TD	Toronto Dominion Bank
2024/07/31	02 : 14	PR Newswire (US)	Rhombus Announces $45M Series C Funding to Extend Global Footprint, Led by NightDragon
2024/07/31	02 : 13	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	02 : 13	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

Bank of America

Deutsche Telekom (QX)

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約